Establishment of NOD/SCID Mouse Models of Human Hepatocellular Carcinoma Via Subcutaneous Transplantation of Histologically Intact Tumor Tissue

Overview

Journal Chin J Cancer Res

Specialty Oncology

Date 2013 Jul 5

PMID 23825905

Citations 11

Authors

Mingxia Yan

Hong Li

Fangyu Zhao

Lixing Zhang

Chao Ge

Ming Yao

Jinjun Li

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is one of the most deadly human cancers, but it is very difficult to establish an animal model by using surgical specimens. In the present experiment, histologically intact fresh surgical specimens of HCC were subcutaneously transplanted in non-obese diabetic/severe combined immunodeficienccy (NOD/SCID) mice. The biological characteristics of the original and the corresponding transplanted tumors and cell lines were investigated. The results showed that 5 new animal models and 2 primary cell lines were successfully established from surgical specimens. Hematoxylin-eosin staining showed that xenografts retained major histological features of the original surgical specimens. The two new cell lines had been cultivated for 3 years and successively passaged for more than 100 passages in vitro. The morphological characteristics and biologic features of the two cell lines were genetically similar to the original tumor. The subcutaneous transplant animal models with histologically intact tumor tissue and primary cell lines could be useful for in vivo and in vitro testing of anti-cancer drugs and be ideal models to study various biologic features of HCC.

Citing Articles

State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment.

Giron-Michel J, Padelli M, Oberlin E, Guenou H, Duclos-Vallee J BioDrugs. 2025; 39(2):237-260.

PMID: 39826071 PMC: 11906529. DOI: 10.1007/s40259-024-00702-0.

Establishment and characterization of a highly metastatic hepatocellular carcinoma cell line.

Huang J, Sun M, Wang M, Yu A, Zheng H, Bu C Bioengineered. 2024; 15(1):2296775.

PMID: 38184822 PMC: 10773622. DOI: 10.1080/21655979.2023.2296775.

Patient-derived models facilitate precision medicine in liver cancer by remodeling cell-matrix interaction.

Chen K, Li Y, Wang B, Yan X, Tao Y, Song W Front Immunol. 2023; 14:1101324.

PMID: 37215109 PMC: 10192760. DOI: 10.3389/fimmu.2023.1101324.

In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling.

Romualdo G, Leroy K, Costa C, Prata G, Vanderborght B, Da Silva T Cancers (Basel). 2021; 13(21).

PMID: 34771745 PMC: 8582701. DOI: 10.3390/cancers13215583.

Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity.

Chen X, Shen C, Wei Z, Zhang R, Wang Y, Jiang L Cancer Biol Med. 2021; 18(1):184-198.

PMID: 33628593 PMC: 7877179. DOI: 10.20892/j.issn.2095-3941.2020.0012.

References

Sanchez A, Fabregat I . Genetically modified animal models recapitulating molecular events altered in human hepatocarcinogenesis. Clin Transl Oncol. 2009; 11(4):208-14. DOI: 10.1007/s12094-009-0342-x. View

Liao R, Wu H, Yi Y, Wang J, Cai X, He H . Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma. J Exp Clin Cancer Res. 2013; 32:22. PMC: 3654985. DOI: 10.1186/1756-9966-32-22. View

Jung K, Zheng H, Jeong Y, Choi M, Lee H, Hong S . Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor. Cancer Lett. 2012; 328(1):176-87. DOI: 10.1016/j.canlet.2012.08.005. View

Fujii E, Suzuki M, Matsubara K, Watanabe M, Chen Y, Adachi K . Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse. Pathol Int. 2008; 58(9):559-67. DOI: 10.1111/j.1440-1827.2008.02271.x. View

Arias I . Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance. Clin Cancer Res. 1996; 2(4):695-706. View

Huang P, Tsai S, Luo T, Kao C, Lin W . Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma. Ann Nucl Med. 2013; 27(6):532-7. DOI: 10.1007/s12149-013-0717-5. View

Sun F, Tang Z, Lui K, Ye S, Xue Q, Gao D . Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer. 1996; 66(2):239-43. DOI: 10.1002/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.0.CO;2-7. View

Li Y, Tang Z, Ye S, Liu Y, Chen J, Xue Q . [Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection]. Zhonghua Yi Xue Za Zhi. 2002; 82(9):601-5. View

Merk J, Rolff J, Becker M, Leschber G, Fichtner I . Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?. Eur J Cardiothorac Surg. 2009; 36(3):454-9. DOI: 10.1016/j.ejcts.2009.03.054. View

10.

Saito H, Morizane T, Watanabe T, Kagawa T, Iwabuchi M, Kumagai N . Establishment of a human cell line (HCC-T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection. Cancer. 1989; 64(5):1054-60. DOI: 10.1002/1097-0142(19890901)64:5<1054::aid-cncr2820640516>3.0.co;2-x. View

11.

Tian J, Tang Z, Ye S, Liu Y, Lin Z, Chen J . New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer. 1999; 81(5):814-21. PMC: 2374300. DOI: 10.1038/sj.bjc.6690769. View

12.

Yang Y, Jin C, Li H, He Y, Liu Z, Bai L . Improved radiosensitizing effect of the combination of etanidazole and paclitaxel for hepatocellular carcinoma in vivo. Exp Ther Med. 2012; 3(2):299-303. PMC: 3438662. DOI: 10.3892/etm.2011.389. View

13.

Visonneau S, Cesano A, Torosian M, Miller E, Santoli D . Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice. Am J Pathol. 1998; 152(5):1299-311. PMC: 1858587. View

14.

Yau W, Lam C, Ng L, Chow A, Chan S, Chan J . Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process. PLoS One. 2013; 8(3):e57882. PMC: 3590302. DOI: 10.1371/journal.pone.0057882. View

15.

Fichtner I, Rolff J, Soong R, Hoffmann J, Hammer S, Sommer A . Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. Clin Cancer Res. 2008; 14(20):6456-68. DOI: 10.1158/1078-0432.CCR-08-0138. View

16.

Wu L, Tang Z, Li Y . Experimental models of hepatocellular carcinoma: developments and evolution. J Cancer Res Clin Oncol. 2009; 135(8):969-81. DOI: 10.1007/s00432-009-0591-7. View

17.

Li Y, Tian B, Yang J, Zhao L, Wu X, Ye S . Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J Cancer Res Clin Oncol. 2004; 130(8):460-8. DOI: 10.1007/s00432-004-0564-9. View

18.

Tang Z, Ye S, Liu Y, Qin L, Sun H, Ye Q . A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2003; 130(4):187-96. DOI: 10.1007/s00432-003-0511-1. View

19.

Rheinwald J, Beckett M . Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 1981; 41(5):1657-63. View

20.

Milane L, Duan Z, Amiji M . Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer. Nanomedicine. 2011; 7(4):435-44. PMC: 3136558. DOI: 10.1016/j.nano.2010.12.009. View